LBel ParisRegression Jour (Ventura International LTD)


Welcome to the PulseAid listing for the LBel Paris drug offered from Ventura International LTD. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: Ventura International LTD
NON-PROPRIETARY NAME: Avobenzone, Ensulizole, Octinoxate, and Oxybenzone
SUBSTANCE NAME: AVOBENZONE; ENSULIZOLE; OCTINOXATE; OXYBENZONE
TYPE: HUMAN OTC DRUG
PHARMA CLASS:
ROUTE: TOPICAL
DOSAGE FORM: CREAM
MARKETING CATEGORY NAME: OTC MONOGRAPH FINAL
START MARKETING DATE: 2010-08-15
END MARKETING DATE: 0000-00-00


LBel Paris Regression Jour HUMAN OTC DRUG Details:

Item DescriptionLBel Paris Regression Jour from Ventura International LTD
LABELER NAME: Ventura International LTD
DEA SCHEDULE:
ACTIVE STRENGTH: .1; .05; .375; .1(g/5g; g/5g; g/5g; g/5g)
START MARKETING DATE: 2010-08-15
END MARKETING DATE: 0000-00-00
PRODUCT ID: 14783-039_35041b4f-d141-4cf0-91c9-829ff347fe90
PRODUCT NDC: 14783-039
APPLICATION NUMBER: part352

Other AVOBENZONE; ENSULIZOLE; OCTINOXATE; OXYBENZONE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Ventura Corporation Ltd.LBEL REGRESSION JOUR
Ventura International LTDLBel Paris
Ventura International Ltd.LBEL REGRESSION JOUR